Even if rem_l is 20% better than SOC, that's 300 patients on1500 deaths.
Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial, page-192
-
- There are more pages in this discussion • 201 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.54 |
Change
0.023(1.49%) |
Mkt cap ! $1.712B | |||
| Open | High | Low | Value | Volume |
| $1.50 | $1.54 | $1.48 | $4.917M | 3.262M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 32 | 32423 | $1.54 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.54 | 85301 | 13 |
View Market Depth
| Last trade - 15.46pm 13/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |